@RaceOncology
Just an aside. I understand the appointment of CCSA was prior to the announcement of the 3 pillar strategy but I see that this article on the RAC website says it is following "our existing 5-path strategy" which at the time was correct, but is now a 3-pillar strategy. I understand this is a small issue but it would be great to see if this could be updated potentially to reflect the current strategy of RAC - thanks!
Source:
https://www.raceoncology.com/race-appoints-clinical-and-fda-regulatory-strategy-advisor/
Hiring Principle Scientist – Ph.D - Oncology, page-25
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |